Avenue Therapeutics, Inc. (ATXI) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 2.42M | 2.85M | 3.71M | 4.16M | 3.59M | 2.67M | 2.63M | 4.99M | 3.31M | 1.85M | 502K | 1.67M | 8.45M | 6.84M | 575K | 1M | 1.96M | 3.96M | 688K | 1.19M |
| Cash & Short-Term Investments | 2.42M | 2.85M | 3.71M | 3.33M | 3.5M | 2.59M | 2.6M | 4.92M | 3.19M | 1.78M | 161K | 1.57M | 8.24M | 6.71M | 217K | 890K | 1.83M | 3.76M | 585K | 1.12M |
| Cash Only | 2.42M | 2.85M | 3.71M | 3.33M | 3.5M | 2.59M | 2.6M | 4.92M | 3.19M | 1.78M | 161K | 1.57M | 8.24M | 6.71M | 217K | 890K | 1.83M | 3.76M | 585K | 1.12M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 800K | 0 | 0 | 0 | 0 | 0 | 0 | 13K | 26K | 0 | 0 | 0 | 0 | 0 | 90K | 74K | 0 |
| Days Sales Outstanding | - | - | - | 51.85 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 310K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 35K | 92K | 78K | 28K | 69K | 116K | 67K | 0 | 69K | 13K | 0 | 338K | 0 | 0 | 107K | 0 | 0 |
| Total Non-Current Assets | 0 | 76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67K | 310K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67K | 310K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 2.47M | 2.93M | 3.73M | 4.16M | 3.59M | 2.67M | 2.63M | 4.99M | 3.31M | 1.85M | 502K | 1.67M | 8.45M | 6.84M | 575K | 1M | 1.96M | 3.96M | 688K | 1.19M |
| Asset Turnover | - | - | - | 0.36x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -31.33% | 9.69% | 41.9% | -16.58% | 8.58% | 44.43% | 422.91% | 199.4% | -60.81% | -72.97% | -12.7% | 65.77% | 331.85% | 72.85% | -16.42% | -15.62% | 0.62% | 22.03% | -84.19% | -77.66% |
| Total Current Liabilities | 1.27M | 1.1M | 1.42M | 1.33M | 1.26M | 816K | 973K | 1.16M | 1.41M | 1.2M | 5.02M | 7.81M | 10.6M | 3.58M | 614K | 407K | 797K | 509K | 848K | 549K |
| Accounts Payable | 0 | 0 | 490K | 79K | 173K | 155K | 140K | 592K | 662K | 401K | 560K | 500K | 374K | 150K | 364K | 303K | 493K | 362K | 202K | 82K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.27M | 1.1M | 391K | 107K | 86K | 34K | 316K | 47K | 413K | 586K | 3.3M | 5.87M | 5.72M | 2.61M | 90K | 0 | 45K | 123K | 0 | 0 |
| Current Ratio | 1.90x | 2.60x | 2.61x | 3.13x | 2.85x | 3.27x | 2.70x | 4.30x | 2.34x | 1.55x | 0.10x | 0.21x | 0.80x | 1.91x | 0.94x | 2.47x | 2.45x | 7.78x | 0.81x | 2.17x |
| Quick Ratio | 1.90x | 2.60x | 2.61x | 3.13x | 2.85x | 3.27x | 2.70x | 4.30x | 2.34x | 1.55x | 0.04x | 0.21x | 0.80x | 1.91x | 0.94x | 2.47x | 2.45x | 7.78x | 0.81x | 2.17x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.27M | 1.1M | 1.42M | 1.33M | 1.26M | 816K | 973K | 1.16M | 1.41M | 1.2M | 5.02M | 7.81M | 10.6M | 3.58M | 614K | 407K | 797K | 509K | 848K | 549K |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -2.42M | -2.85M | -3.71M | -3.33M | -3.5M | -2.59M | -2.6M | -4.92M | -3.19M | -1.78M | -161K | -1.57M | -8.24M | -6.71M | -217K | -890K | -1.83M | -3.76M | -585K | -1.12M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | -11.20x | - | - | - | - | - | - | -0.31x | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | -21.90x | 1.46x | - | - | - | - | - | - |
| Total Equity | 1.2M | 1.83M | 2.3M | 2.83M | 2.33M | 1.86M | 1.65M | 3.83M | 1.9M | 654K | -4.52M | -6.15M | -2.16M | 3.27M | -39K | 598K | 1.16M | 3.45M | -160K | 642K |
| Equity Growth % | -48.63% | -1.29% | 39.41% | -26% | 22.87% | 183.79% | 136.53% | 162.27% | 187.99% | -79.98% | -11494.87% | -1127.76% | -286.11% | -5.36% | 75.63% | -6.85% | -21.42% | 46.29% | -104.95% | -84.35% |
| Book Value per Share | 0.36 | 0.59 | 0.72 | 0.89 | 0.78 | 1.16 | 1.03 | 3.42 | 3.38 | 0.03 | -0.56 | -59.41 | -0.39 | 2.32 | -0.03 | 0.41 | 0.83 | 2.84 | -0.14 | 0.58 |
| Total Shareholders' Equity | 1.2M | 1.83M | 3.56M | 4.06M | 3.51M | 2.8M | 2.61M | 4.76M | 2.84M | 1.58M | -3.65M | -5.34M | -1.45M | 3.9M | -39K | 598K | 1.16M | 3.45M | -160K | 642K |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 1K | 1K | 1K | 0 | 0 | 2K | 2K | 2K | 2K | 2K |
| Retained Earnings | -106.18M | -105.49M | -104.78M | -104.1M | -104.43M | -102.58M | -101.04M | -97.96M | -95.27M | -90.93M | -91.57M | -92.09M | -88.09M | -80.55M | -81.13M | -80.46M | -79.86M | -77M | -76.09M | -75.22M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | -1.25M | -1.23M | -1.18M | -941K | -958K | -937K | -938K | -928K | -872K | -810K | -705K | -639K | 0 | 0 | 0 | 0 | 0 | 0 |